THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE
Aim. To estimate an effect of metabolic corrector mildronate on cardiac hemodynamics and endothelium function in patients with ischemic heart disease (IHD) and heart failure (HF)Material and methods. 60 patients with IHD and HF of I-III functional class according to NYHA were included into the study...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/497 |
| _version_ | 1797232413656481792 |
|---|---|
| author | I. V. Sergienko M. E. Bugriy T. V. Balahonova G. A. Tkachev V. B. Sergienko |
| author_facet | I. V. Sergienko M. E. Bugriy T. V. Balahonova G. A. Tkachev V. B. Sergienko |
| author_sort | I. V. Sergienko |
| collection | DOAJ |
| description | Aim. To estimate an effect of metabolic corrector mildronate on cardiac hemodynamics and endothelium function in patients with ischemic heart disease (IHD) and heart failure (HF)Material and methods. 60 patients with IHD and HF of I-III functional class according to NYHA were included into the study. 30 patients of the main group received mildronate at a daily dose of 1000 mg during 3 months additionally to standard therapy. Patients of the control group took standard therapy only. Cardiac function was estimated by 4D Gated Equilibrium Radionuclide Ventriculography. The endothelium function was measured as endothelium dependent vasodilation.Results. During 3 months mildronate therapy resulted in increase of left ventricular (LV) ejection fraction, peak filling and peak ejecting rate of LV.Conclusion. Metabolic corrector mildronate has positive effect on cardiac function in patients with IHD and CHF. |
| first_indexed | 2024-03-08T14:05:24Z |
| format | Article |
| id | doaj.art-d853730b87fa435c9eb32db5889d9763 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:59:53Z |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-d853730b87fa435c9eb32db5889d97632024-04-01T07:43:26ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-0134253110.20996/1819-6446-2007-3-4-25-31497THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILUREI. V. Sergienko0M. E. Bugriy1T. V. Balahonova2G. A. Tkachev3V. B. Sergienko4Russian Cardiological Research Complex of Rosmedtechnology, MoscowRussian Cardiological Research Complex of Rosmedtechnology, MoscowRussian Cardiological Research Complex of Rosmedtechnology, MoscowRussian Cardiological Research Complex of Rosmedtechnology, MoscowRussian Cardiological Research Complex of Rosmedtechnology, MoscowAim. To estimate an effect of metabolic corrector mildronate on cardiac hemodynamics and endothelium function in patients with ischemic heart disease (IHD) and heart failure (HF)Material and methods. 60 patients with IHD and HF of I-III functional class according to NYHA were included into the study. 30 patients of the main group received mildronate at a daily dose of 1000 mg during 3 months additionally to standard therapy. Patients of the control group took standard therapy only. Cardiac function was estimated by 4D Gated Equilibrium Radionuclide Ventriculography. The endothelium function was measured as endothelium dependent vasodilation.Results. During 3 months mildronate therapy resulted in increase of left ventricular (LV) ejection fraction, peak filling and peak ejecting rate of LV.Conclusion. Metabolic corrector mildronate has positive effect on cardiac function in patients with IHD and CHF.https://www.rpcardio.online/jour/article/view/497metabolic correctorischemic heart diseaseheart failurecardiac hemodynamics |
| spellingShingle | I. V. Sergienko M. E. Bugriy T. V. Balahonova G. A. Tkachev V. B. Sergienko THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE Рациональная фармакотерапия в кардиологии metabolic corrector ischemic heart disease heart failure cardiac hemodynamics |
| title | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE |
| title_full | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE |
| title_fullStr | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE |
| title_full_unstemmed | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE |
| title_short | THE POSSIBILITY OF USAGE OF METABOLIC CORRECTION THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AND HEART FAILURE |
| title_sort | possibility of usage of metabolic correction therapy in patients with ischemic heart disease and heart failure |
| topic | metabolic corrector ischemic heart disease heart failure cardiac hemodynamics |
| url | https://www.rpcardio.online/jour/article/view/497 |
| work_keys_str_mv | AT ivsergienko thepossibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT mebugriy thepossibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT tvbalahonova thepossibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT gatkachev thepossibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT vbsergienko thepossibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT ivsergienko possibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT mebugriy possibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT tvbalahonova possibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT gatkachev possibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure AT vbsergienko possibilityofusageofmetaboliccorrectiontherapyinpatientswithischemicheartdiseaseandheartfailure |